Rufeng Xie

621 citations
30 papers · 496 indexed · h-index 13
Topics
Immunotherapy and Immune Responses (8 papers)T-cell and B-cell Immunology (8 papers)Hematopoietic Stem Cell Transplantation (5 papers)
Partner nations
ChinaUnited States

In The Last Decade

Rufeng Xie

29 papers receiving 490 citations

Peers

Rufeng Xie
Comparison fields: 5 of 93
  • Immunology 178
  • Molecular Biology 173
  • Hematology 85
  • Oncology 61
  • Cancer Research 55
Replace Su Zhang with:
Su Zhang Sweden
Yanfeng Zhao China
Hadi Rezaeeyan Iran
Jean-Marie Freyssinet France
Tomoaki Doi Japan
Nikita Joshi United States
Fiona R. Green United Kingdom
Alicia N. Rizzo United States
Lidia Michalec United States
Maria Teresa Herrera Abreu Canada
Rufeng Xie relative to Su Zhang Sweden Su Zhang's profile →
Citations per field
00.5×1.5×
Su Zhang · 1×
Citations per year

Countries citing papers authored by Rufeng Xie

Since Specialization
Citations

This map shows the geographic impact of Rufeng Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufeng Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufeng Xie more than expected).

Fields of papers citing papers by Rufeng Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rufeng Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufeng Xie. The network helps show where Rufeng Xie may publish in the future.

Co-authorship network of co-authors of Rufeng Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Rufeng Xie. A scholar is included among the top collaborators of Rufeng Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rufeng Xie. Rufeng Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 25
4 18
5 0
6 16
7 6
8 24
9 8
10 30
11 1
12 20
13 11
14 7
15 30
16
[The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
1
17 20
18 11
19 39
20 24

About Rufeng Xie

Rufeng Xie is a scholar working on Immunology, Hematology and Biochemistry, having authored 30 papers that have together received 496 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (8 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Immunology (178 citations), Hematology (85 citations) and Biochemistry (29 citations). Rufeng Xie has collaborated with scholars based in China and United States. Frequent co-authors include Jie Yang, Yiming Yang, Yuan Lu, Zhicheng Wang, Huahua Fan, Jie Wang, Ruilai Liu, Li Gao, Kaicheng Qian and Juan Sun. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026